Vall Hebron Institut de Recerca
Continue with FacebookLooking to list your PhD opportunities? Log in here.
prostate PhD Projects, Programmes & Scholarships
We have 17 prostate PhD Projects, Programmes & Scholarships
PhD saved successfully
Prostate cancer signalling to the bone micro-environment - from molecular characterization to potential novel therapies.
About the Project. Prostate cancer is responsible for over 52,000 cancer diagnoses within the UK per annum, and is the most common cancer in males, accounting for 27% of all new cancer cases diagnosed within men in 2016-2017. Read more
4-year PhD Studentship: An investigation into the performance of screening and diagnostic variables to predict 15-year prostate cancer mortality informing diagnostic and treatment strategies.
Prostate cancer is the UK’s commonest male cancer and represents a significant public health challenge. The UK National Screening Committee currently does not recommend prostate cancer screening1. Read more
Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer
Research Group:
Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more
The role of selective and novel biomarkers and their correlation with clinical outcome measures, pre and post-surgical treatment of benign and malignant disorders of the prostate
The . Maelor Academic Unit of Medical & Surgical Sciences (MAUMSS). Read more
Last chance to apply
Fluorescence spectroscopy and multispectral imaging of cancer-targeted molecular probes
Many common types of solid cancerous tumours exhibit overexpression of certain biomarkers that can be used to distinguish tumour from adjacent normal tissue. Read more
VHIO International PhD Programme Fellowships 2022
Application deadline. June 27, 2022. Apply now to boost your scientific career at VHIO, a Center of Excellence backed by first class core technologies and a broad training portfolio in one of the best translational, preclinical and clinical research centers in Europe. Read more
Artificial Intelligence to Enable Omics Integration - Delivering Enhanced Data Utilisation for Biomarker Discovery
This is a great opportunity for an enthusiastic student to be trained in the cutting-edge disciplines of artificial intelligence (AI) and Machine Learning (ML), intersected with medicine and biology, as well as biomarker technologies for characterisation of human disease and wellness. Read more
Developing nanoparticles to target neuroendocrine tumour for overcoming resistance to cancer treatment
Many cancer patients having undergone local and systemic treatment eventually develop and die from the progression of distant metastasis associated with the relapse in primary tumour growth. Read more
Developing new cancer therapeutic agents from foodstuff: characterizing galectin interaction with novel inhibitors
Applications will be reviewed until a suitable candidate is appointed. Galectins are a family of carbohydrate-binding proteins that are commonly over-expressed by many types of cancers such as colorectal, lung, breast, prostate cancer and melanoma. Read more
Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions
Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more
Synthesis of New Anti-Cancer Agents and Pharmacogenomics of BRCA-mutated Cancers in the Qatar Population
The group has published on the discovery of heterocyclic quinone anti-cancer agents with specificity towards hypoxic cells associated with solid tumours… Read more
Studying of cancer biology with doped magnetic nanomaterials to unravelling their thermal therapeutic potentials
Cancer has a major impact on society, this is reflected by the large number of newly diagnosed cases (375,400 annually for the years 2015-2018 in the UK, i.e. Read more
Development of chemical tools and bioactive compounds to explore the importance of enzyme activity in cancer diseases
Diversity-oriented synthesis (DOS) is a modern chemical methodology, which aims to synthesise small molecules that cover new chemical space with the possibility of finding unexplored biological targets or pathways that may be important for disease progression. Read more
Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy. Read more
Characterisation of enhanced bacterial immunotherapy to treat colorectal cancer
Theoretically, RNA interference to reduce oncogene expression is an attractive therapeutic intervention to reduce tumour burden. Read more
- 1
- 2